• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Smith & Nephew Snats ADR (NY: SNN )

    25.28 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,338
    Open 25.28
    Bid (Size) 25.64 (3)
    Ask (Size) 25.67 (7)
    Prev. Close 25.28
    Today's Range 25.28 - 25.28
    52wk Range 23.65 - 31.72
    Shares Outstanding N/A
    Dividend Yield 3.66%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Estée Lauder, Robinhood, eBay And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design
    From Smith & Nephew UK Ltd
    Via GlobeNewswire

    Performance

    YTD
    -5.85%
    -5.85%
    1 Month
    -12.22%
    -12.22%
    3 Month
    -14.13%
    -14.13%
    6 Month
    +2.14%
    +2.14%
    1 Year
    +4.46%
    +4.46%

    More News

    Read More
    Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery
    From Smith & Nephew UK Ltd
    Via GlobeNewswire
    Smith+Nephew raises the bar in knee revisions by launching new LEGION™ Hinged Knee System with OXINIUM™ Technology
    From Smith & Nephew UK Ltd
    Via GlobeNewswire
    First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility
    From Smith & Nephew UK Ltd
    Via GlobeNewswire
    3D Systems Expands Orthopedic Surgical Planning Portfolio Receiving FDA Clearance for Key Ankle Indications
    From 3D Systems Inc.
    Via GlobeNewswire
    Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides
    From Smith & Nephew UK Ltd
    Via GlobeNewswire
    AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
    From AVITA Medical
    Via GlobeNewswire
    Smith+Nephew partners with HOPCo to provide AI-powered analytics and solutions to ASC customers
    From Smith & Nephew UK Ltd
    Via GlobeNewswire
    Best-in-class just got better; Smith+Nephew announces 510(k) clearance of new CATALYSTEM™ Primary Hip System
    From Smith & Nephew UK Ltd
    Via GlobeNewswire
    Smith+Nephew is trailblazing a new path for female surgeons with its Orthopaedics for All initiative; a first-of-its-kind global advisory board
    From Smith & Nephew UK Ltd
    Via GlobeNewswire
    Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Macy's, Koss And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge
    Via Benzinga
    Smith+Nephew takes centre court sponsoring players competing at Wimbledon; global Sports Medicine technology leader helping athletes get back in the game
    From Smith & Nephew UK Ltd
    Via GlobeNewswire
    Smith+Nephew personalizes robotic-assisted surgery for patients and surgeons with launch of CORIOGRAPH™ Pre-Operative Planning and Modeling Services exclusively for the CORI™ Surgical System
    From Smith & Nephew UK Ltd
    Via GlobeNewswire
    4 Stocks to Watch in the Booming Regenerative Medicine Market
    Via TheNewswire.com
    4 Stocks to Watch in the Booming Regenerative Medicine Market
    Via News Direct
    Current Analysis: Smith & Nephew
    Via Talk Markets
    Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention
    From Smith & Nephew UK Ltd
    Via GlobeNewswire
    Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
    From Smith & Nephew UK Ltd
    Via GlobeNewswire
    Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds
    From Smith & Nephew UK Ltd
    Via GlobeNewswire
    Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner
    From Smith & Nephew UK Ltd
    Via GlobeNewswire
    7 Robotic Surgery Stocks to Buy for the Future of Healthcare
    Via InvestorPlace
    British MedTech Firm Smith & Nephew Seeks To Adopt US-Inspired Pay Policy to Navigate Shareholder Skepticism
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.